OIA Response: Pembrolizumab and nivolumab data

Request dated 29 January 2019 for information relating to Special Authorities for pembrolizumab and nivolumab for November and December 2018.

27 February 2019

[Name and contact details redacted]

Dear [Name redacted]

REQUEST FOR INFORMATION

Thank you for your request dated 29 January 2019 under the Official Information Act 1982 (OIA) for information relating to Special Authorities for pembrolizumab and nivolumab for November and December 2018.

Special Authority applications and approvals for pembrolizumab:

Month submitted

Initial Applications

Approvals - initial

Renewal Applications

Approvals - Renewal

Total applications

Total approvals

November

30

26

41

33

71

59

December

25

19

67

56

92

75

Special Authority applications and approvals for nivolumab:

Month submitted

Initial Applications

Approvals - initial

Renewal Applications

Approvals - Renewal

Total applications

Total approvals

November

0

0

0

0

0

0

December

0

0

7

7

7

7

Please note that the figures represent the total applications and total approvals and include initial, renewal and (within total applications) declined applications. This means that an individual with an initial approval and renewal approvals will be counted multiple times, as will an individual whose application has been declined if they subsequently reapplied.

We trust that the provision of this information answers your queries, if you have any further questions please feel free to contact us again.

Yours sincerely

[Alison Hill's signature]

Alison Hill
Director, Engagement and Implementation